2024 U.S. Drugs of Abuse POC/Decentralized Testing Market: Country Supplier Shares, Test Volume and Sales Segment Forecasts

August 2024 | - | ID: 27C95FB36067EN
Venture Planning Group

Abstracts

This new 165-page report from LeadingMarketResearch.com contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.Market Segmentation Analysis%li%Review of three POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.%li%Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment:%li%Physician Offices/Group Practices %li%Emergency Rooms %li%Ambulatory Care Centers %li%Analysis of drugs of abuse procedures Competitive Assessments%li%Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.Strategic Recommendations%li%Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.%li%Design criteria for POC testing products.%li%Alternative business expansion strategies.%li%Potential market entry barriers and risks.MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.Contains 165 pages and 14 tables

Contents

Introduction
Executive Summary
Rationale for Testing Decentralization

1. OVERVIEW

2. REGULATORY TRENDS

3. ECONOMIC TRENDS

4. DEMOGRAPHIC TRENDS

5. TECHNOLOGICAL TRENDS

6. SOCIAL TRENDS

7. QUALITY OF CARE

8. DEFENSIVE MEDICINE

9. QUALITY CONTROL ISSUES

Worldwide Market and Technology Overview

1. OVERVIEW

2. TEST METHODOLOGIES

3. AMPHETAMINES

4. BARBITURATES

5. BENZODIAZEPINES

6. CANNABINOIDS/MARIJUANA

7. COCAINE

8. LYSERGIC ACID DIETHYLAMIDE (LSD)

9. METHADONE

10. METHAQUALONE

11. OPIATES

12. PHENCYCLIDINE

Worldwide Business Environment
U.S.A.
A. Market Overview

1. BUSINESS ENVIRONMENT

a. Health Care Expenditures
b. Cost Consciousness
Table of Contents (continued)
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations

2. MARKET STRUCTURE

a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices

1. MARKET SUMMARY

2. MARKET STRUCTURE

3. DRUGS OF ABUSE TEST VOLUME AND SALES FORECASTS

C. Ancillary Hospital Locations

1. INTRODUCTION

2. EMERGENCY DEPARTMENTS

a. Market Summary
b. Drugs of Abuse Test volume and Sales Forecasts
D. Ambulatory Care Centers

1. INTRODUCTION

2. MARKET SUMMARY

3. MARKET STRUCTURE

4. DRUGS OF ABUSE TEST VOLUME AND SALES FORECASTS